Cardio Technologies Plans Spring 1999 Cardiogenic Shock Device Study
This article was originally published in The Gray Sheet
Executive Summary
Cardio Technologies is planning to submit an investigational device exemption application to FDA in spring 1999 to begin U.S. clinical trials of the Cardio Support System for acute and chronic heart failure patients experiencing cardiogenic shock.